2016年
- Yamanaka M, Matsumura T, Ohno R, Fujiwara Y, Shinagawa M, Sugawa H, Hatano K, Shirakawa J, Kinoshita H, Ito K, Sakata N, Araki E, Nagai R: Non-invasive measurement of skin autofluorescence to evaluate diabetic complications. J Clin Biochem Nutr 58:135-140, 2016.
- Fujisaka S, Ussar S, Clish C, Devkota S, Dreyfuss JM, Sakaguchi M, Soto M, Konishi M, Softic S, Altindis E, Li N, Gerber G, Bry L, Kahn CR: Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest 126(12):4430-4443, 2016.
- Winnay JN, Solheim MH, Dirice E, Sakaguchi M, Noh HL, Kang HJ, Takahashi H, Chudasama KK, Kim JK, Molven A, Kahn CR, Njølstad PR: PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Invest 126(4):1401-1412, 2016.
- Araki E, Onishi Y, Kim H, Ekholm K, Jhonsson E, Yajima T: Efficacy and safety of dapaglifrozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blinded treatment period. J Diabetes Invest 2016, in press.
- Igata M, Tsuruzoe K, Kawashima J, Kukidome D, Kondo T, Motoshima H, Shimoda S, Furukawa N, Nishikawa T, Miyamura N, Araki E: Coexistence of resistance to thyroid hormone (RTHβ) and papillary thyroid carcinoma. Endocrinology, Diabetes & Metabolism 2016:16-0003, 2016.
- Shimoda S, Sato M, Sekigami T, Motoshima H, Yoshimura R, Fukuda K, Matsuo Y, Noda H, Okubo M, Ichimori S, Fujisawa K, Fukunaga M, Araki E; Kumamoto Insulin Degludec Observational (KIDUNA) Study Group: A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study). J Diabetes Invest 7(5):703-710, 2016.
- Hanatani S, Motoshima H, Takaki Y, Kawasaki S, Igata M, Matsumura T, Kondo T, Senokuchi T, Ishii N, Kawashima J, Kukidome D, Shimoda S, Nishikawa T, Araki E. Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice. J Clin Biochem Nutr 59(3):207-214, 2016.
- Sada K, Nishikawa T, Kukidome D, Yoshinaga T, Kajihara N, Sonoda K, Senokuchi T, Motoshima H, Matsumura T, Araki E: Hyperglycemia induces cellular hypoxia through production of mitochondrial ROS followed by suppression of aquaporin-1. PLOS One 11(7):e0158619, 2016.
- Inagaki N, Araki E, Oura T, Matsui A, Takeuchi M, Tanizawa Y: The combination of dulaglutide and biguanide reduced body weight in Japanese patients with type 2 diabetes. Diabetes Obes Metab 18(12):1279-1282, 2016.
- Nishikawa T, Araki E: Involvement of advanced glycation end-products in 'hyperglycemic memory'. J Diabetes Investig 7(3):297-299, 2016.
- Ishibashi S, Yamashita S, Arai H, Araki E, Yokote K, Suganami H, Fruchart JC, Kodama T; K-877-04 Study Group: Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. Atherosclerosis 249:36-43, 2016.
- Kukidome D, Nishikawa T, Sato M, Igata M, Kawashima J, Shimoda S, Matsui K, Obayashi K, Ando Y, Araki E: Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy. Diabet Med 33(1):62-69, 2016.
- Kondo T, Goto R, Ono K, Kitano S, Suico MA, Sato M, Igata M, Kawashima J, Motoshima H, Matsumura T, Kai H, Araki E: Activation of heat shock response to treat obese subjects with type 2 diabetes: a prospective, frequency-escalating, randomized, open-label, triple-arm trial. Sci Rep 6:35690, 2016.
- Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T: New glysemic targets for patients with diabetes from the Japan Diabetes Society. Diabetology International 7(4):327-330, 2016.
